Source: Health Products Regulatory Authority (ZA) Revision Year: 2022 Publisher: Adcock Ingram Limited, 1 New Road, Erand Gardens, Midrand, 1685, Private Bag X69, Bryanston, 2021, www.adcock.com, 0860ADCOCK (232625)
BETAFLEX NC.
Strength
Each Tablet contains:
Paracetamol 450 mg
Orphenadrine citrate 35 mg
Pharmaceutical form:
Tablet
| Pharmaceutical Form |
|---|
|
White, circular, biconvex tablets with a breakbar on one face. |
Each Tablet contains:
Paracetamol 450 mg
Orphenadrine 35 mg
Sugar free
For a full list of excipients see section 6.1.
| Active Ingredient |
|---|
|
Orphenadrine, which is a congener of diphenhydramine without sharing its soporific effect, is an anti-muscarinic agent. Orphenadrine is used as the hydrochloride in the symptomatic treatment of Parkinsonism. |
|
Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. |
| List of Excipients |
|---|
|
Colloidal silicon dioxide |
Cartons containing 20 blister packed tablets.
Securitainers of 50 and 100 tablets.
Adcock Ingram Limited, 1 New Road, Erand Gardens, Midrand, 1685, Private Bag X69, Bryanston, 2021, www.adcock.com, 0860ADCOCK (232625)
32/2.8/0606
21/08/2000
| Drug | Countries | |
|---|---|---|
| BETAFLEX | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.